Boston Omaha Corporation
NYSE:BOCAdvertising Agencies
+$0.04 today
- Market cap
- $445.57M
- Beta
- 0.69
- P/E (TTM)
- -29.0
- EPS (TTM)
- -$0.45
Volume 0.26M
Average 0.21M
BOC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Boston Omaha CorporationNYSE: BOC
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of $6.48M (cash outflow) fell 5.5% year over year, ahead of the -10.1% change in trailing-twelve-month capital expenditures. Sequentially, it fell 22.0% from the prior quarter. Over 3 fiscal years it compounded at -11.4% a year.
Context
- Capital expenditures amounted to 24.4% of revenue in FY2025, down 5.3 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -5.5% holds above the trailing-twelve-month pace of -10.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (27.9M) USD
- Year-over-year change
- +13.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (27.9M) | +13.4% |
| FY2024 | 2024-12-31 | (32.2M) | +37.9% |
| FY2023 | 2023-12-31 | (51.87M) | -29.5% |
| FY2022 | 2022-12-31 | (40.06M) | -90.7% |
| FY2021 | 2021-12-31 | (21.01M) | — |
Capital Expenditures vs competitors
How BOC compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -10.1% is the 5th highest of 9, against a peer median of -10.8%.
- Capital expenditures amounts to 24.0% of revenue for BOC, versus a peer median of 2.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $112M USD | -9.7% | -37.2% | 3.6% | |
| LTM Mar 2026 | $83.86M USD | -12.4% | -20.2% | 2.1% | |
| LTM Mar 2026 | $49.21M USD | -9.4% | -41.9% | 1.4% | |
| LTM Mar 2026 | $27.52M USD | -10.1% | -11.4% | 24.0% | |
| LTM Mar 2026 | $18.83M USD | +21.0% | -7.2% | 5.0% | |
| LTM Dec 2025 | CN¥8.88M CNY | — | +131.6% | 0.3% | |
| LTM Mar 2026 | $8.28M USD | -11.9% | -51.4% | 2.3% | |
| LTM Apr 2026 | $5.2M USD | +4.0% | +24.5% | 2.1% | |
| LTM Mar 2026 | $4.91M USD | -39.6% | +52.6% | 1.1% | |
| LTM Mar 2026 | $31K USD | -99.7% | -89.5% | 0.5% | |
| Peer median (excluding BOC) | — | -10.8% | -20.2% | 2.1% | |
Competitors are the stored peer set for BOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 55.48M | 10.23M | (6.17M) | 3.37M | (12.43M) |
| Depreciation & Amortization | 14.69M | 20.64M | 25.27M | 27.89M | 30.66M |
| Deferred Income Tax | 17.69M | (2.82M) | (3.08M) | (290.43K) | (136.67K) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 14.32M | (19.34M) | (2.33M) | 2.31M | (7.9M) |
| Accounts Receivables | 191.45K | (1.58M) | (6.55M) | (508.99K) | 458.6K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | (12.28M) | 0 | 0 | (1.81M) |
| Other Working Capital | 14.13M | (5.47M) | 4.22M | 2.82M | (6.55M) |
| Other Non-Cash Items | (94.41M) | (13.89M) | 2.36M | (12.04M) | 7.66M |
| Operating Cash Flow | 7.77M | (5.17M) | 16.06M | 21.24M | 17.86M |
| Capital Expenditures | (21.01M) | (40.06M) | (51.87M) | (32.2M) | (27.9M) |
| Acquisitions (Net) | (96.76M) | (167.83M) | (17.98M) | (517.9K) | (14.51K) |
| Purchases of Investments | (1.65B) | (160.63M) | (298.64M) | (294.26M) | (273.42M) |
| Sales of Investments | 1.7B | 341.12M | 304.48M | 355.08M | 287.78M |
| Other Investing Activities | 20M | 0 | (248.27K) | 0 | 0 |
| Investing Cash Flow | (45.67M) | (27.41M) | (64.25M) | 28.1M | (13.55M) |
| Debt Repayment | 6.94M | (1.5M) | (1.16M) | 12.23M | 9.21M |
| Common Stock Issued | 62.85M | (37.48K) | 37.53M | 0 | 525.26K |
| Common Stock Repurchased | 0 | 0 | 0 | (18.35M) | (5.75M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (5.15M) | 7.08M | (3.42M) | (41.43M) | (2.77M) |
| Financing Cash Flow | 64.64M | 5.54M | 32.94M | (47.56M) | 1.21M |
| Effect of Forex Changes | 0 | (11.84M) | 0 | 0 | 0 |
| Net Change in Cash | 26.74M | (38.87M) | (15.25M) | 1.78M | 5.52M |
| Free Cash Flow | (13.24M) | (45.22M) | (35.81M) | (10.96M) | (10.04M) |
Boston Omaha Corporation
NYSE:BOC
Intrinsic Alpha fair value
Locked
Current Price
$14.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.